Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis

The advent of imatinib mesylate (IM) has dramatically revolutionized the prognosis of advanced and metastatic/recurrent gastrointestinal stromal tumors (GISTs). The objective of this retrospective study is to investigate the safety and efficacy of combination of surgery following IM treatment in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian, Yin, Yuan, Shen, Chaoyong, Yin, Xiaonan, Cai, Zhaolun, Pu, Lin, Fu, Wei, Wang, Yaxuan, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478449/
https://www.ncbi.nlm.nih.gov/pubmed/32118738
http://dx.doi.org/10.1097/MD.0000000000019275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478449/
https://www.ncbi.nlm.nih.gov/pubmed/32118738
http://dx.doi.org/10.1097/MD.0000000000019275

Ejemplares similares